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Abstract
Objective—Although the Malawian government recommends HIV-exposed infants receive early
infant diagnosis of HIV (EID) at “under-five” pediatric clinics (U5Cs), most never enroll.
Therefore, we evaluated the integration of EID testing into an immunization clinic (IC) compared
to the current standard of EID testing at an U5C.
Design—Prospective observational study.
Methods—Using routine provider initiated HIV testing and counseling (PITC) registers, we
prospectively studied 1757 children offered PITC at a government IC and U5C. Infants tested by
HIV DNA polymerase chain reaction (PCR) were followed until PCR result disclosure or
defaulting.
Results—We sampled 877 and 880 consecutive PITC recipients at U5C and IC, respectively.
Overall, a 7 fold greater proportion received PITC at IC (84.2% vs 11.4%, p<0.001). PITC
recipients at IC were more than 14 months younger (2.6 vs 17.0, p<0.001), with greater
proportions HIV-exposed (17.6% vs 5.3%, p<0.001) and PCR eligible (7.9% vs 3.5%, p<0.001).
A higher percentage of IC infants accepted PCR testing (100.0% vs 90.3%, p=0.03). Additionally,
IC PCR recipients were 2.5 months younger (3.1 vs 5.6, p<0.001) with 4 times less testing PCR
positive (7.1% vs 32.1%, p<0.001). Importantly, a more than 3 fold greater proportion of HIV-
exposed infants at IC returned for their PCR result and enrolled into care (78.6% vs 25.0%,
p<0.001).
Conclusions—Compared to an U5C, integrating EID testing into an IC is more acceptable,
more feasible, enrolls more infants into EID at younger ages, and would likely strengthen
Malawi's EID services if expanded.
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INTRODUCTION
Malawi, a southern African country with a human immunodeficiency virus (HIV)
prevalence of 11%1, implemented early infant diagnosis of HIV (EID) using DNA
polymerase chain reaction (PCR) in 2007 to improve infant HIV care1. Unfortunately, the
Malawi EID program has underperformed partly due to inadequately coordinated antenatal
and post-natal HIV services2,3. As a result, even though HIV-exposed infants are
recommended to enroll into EID at “under-five” general pediatric clinics (U5Cs), many
instead access EID late or not at all2,3.
One alternative to the current standard of care is to integrate EID into immunization clinics
(ICs), which are accessed by more than 90% of all Malawian children4. In Malawi U5Cs
offer care for sick children, EID, and ICs. Although ICs occur at U5Cs, they remain distinct
from EID. Instead the majority of EID testing at U5Cs takes place only when infants are
brought for PCR especially or if they are sick2,3. IC patients, on the other hand, may be
more ideal EID candidates since they are usually infants without acute illnesses. Therefore,
we evaluated the acceptability, feasibility, and outcomes of EID integrated into an IC
compared to the current standard of EID at an U5C.
MATERIALS AND METHODS
Study Setting
The IC at Bwaila Hospital and the U5C at Kamuzu Central Hospital are busy government
clinics serving Lilongwe's population of 750,000 people4. While both pediatric clinics
receive referrals, the vast majority receiving care at both sites are self-referred. A “pilot”
provider initiated HIV testing and counseling (PITC) program at the IC began in January
2011, while at the U5C PITC services have been offered since June 2010. Each clinic's
PITC service operated Monday to Friday with similar staffing levels and utilized volunteer
patient escorts as described previously5. Specifically, one HIV counselor and one patient
escort staffed one private HIV testing room at the IC, and two HIV counselors and one
patient escort staffed the two private HIV testing rooms at the U5C. Patient escorts are
parents of HIV-infected children responsible for HIV testing advocacy, assisting the
counselor with administrative duties, and accompanying caregivers of HIV-affected infants
from the testing room to the HIV clinic.
At both sites HIV counselors delivered group counseling to caregivers, who were
predominantly mothers. At the IC each caregiver met with the HIV counselor after the child
received the vaccination and was weighed. At the U5C, clinicians and nurses would refer
patients for HIV testing based upon clinical suspicion while PITC staff recruited patients
regardless of their presentation. In the testing rooms at both clinics, the counselor obtained
verbal consent for HIV testing of the infant from the responsible caregiver in compliance
with Malawi HIV testing guidelines6. Accordingly, HIV testing was offered if the mother's
last HIV test was more than three months before that date, she had never been tested or
documentation of her test history was unavailable, or a clinical indication warranted a repeat
test. HIV testing information was recorded on a confidential but non-anonymous PITC
register as outlined previously5. After disclosure of the HIV test result, all newly identified
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HIV-infected or HIV-exposed children were prescribed cotrimoxazole prophylaxis (if older
than 6 weeks) and were accompanied by a patient escort to a nearby HIV clinic.
Study Design
Using the PITC registers, we prospectively sampled a total of 1757 children offered HIV
testing at the IC and U5C, respectively, beginning February 2011. Patients were followed
until disclosure of the PCR result, which was scheduled four weeks after testing according to
EID protocol2. For the purposes of this study, an additional two weeks were allowed for
PCR result disclosure if the patient missed their appointment, at which time they were
considered a defaulter.
De-identified PITC data was entered into an electronic database for analysis. Ethical
approval was obtained from the Malawi National Health Sciences Research Committee,
University of North Carolina-Chapel Hill School of Medicine, and Baylor College of
Medicine. Consent from individual participants was not required since this study was within
the routine operations of the Malawi Ministry of Health PITC program and involved no risk
or direct contact with subjects.
Definitions
Eligible for PCR testing—Children were eligible for PCR if they were younger than 12
months of age, their mother was HIV-infected, and they were not already enrolled in HIV
care elsewhere with a previous or pending PCR.
HIV-exposed—HIV-exposed children were defined as children younger than 12 months of
age and either breastfeeding from an HIV-infected mother or not breastfeeding but without a
definitively negative PCR result.
HIV-infection—HIV-infected children were older than 12 months of age and tested HIV-
antibody positive, or had a documented positive PCR irrespective of their age.
Statistical Methods
The sample was based upon our hypothesis that the proportion of PCRs would represent
3.9% of HIV tests at the U5C and that this would increase to 7.0% at the IC. Associations
between covariates were tested using Chi-square, Fisher's exact, and Wilcoxon signed rank
tests; alpha was 0.05. Analysis was conducted using SAS (SAS institute, Cary, NC, USA).
RESULTS
We sampled 877 and 880 successive PITC recipients at the U5C and IC, respectively
(Figure 1). The uptake of PITC at the IC and the U5C was compared, and we discovered a
7-times greater proportion of children accessed PITC at the IC (84.2% vs 11.4%, p<0.001).
Overall patient characteristics including age, gender, initial HIV status, and PCR eligibility
were evaluated. No difference in gender was identified between infants at both clinics.
However, children that received PITC at the IC were found to be considerably younger (2.6
vs 17.0 months, p<0.001), with much higher percentages identified as HIV-exposed (17.6%
vs 5.3%, p<0.001) and eligible for PCR testing (7.9% vs 3.5%, p<0.001).
This study also assessed the acceptability of EID at both sites and investigated the
characteristics of patients that received a PCR. We found that a higher percentage of infants
at the IC accepted PCR testing (100.0% vs 90.3%, p=0.03). Additionally, PCR recipients at
the IC were 2.5 months younger (3.1 vs 5.6, p<0.001) with higher proportions having
received prevention of mother-to-child HIV transmission (PMTCT) interventions (85.7% vs
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40.0%, p<0.001) and 4 times less PCR positive (7.1% vs 32.1%, p<0.001). We also found
that a more than 3-times higher proportion of HIV-exposed infants at the IC returned to the
counselor after 4 weeks to receive their PCR result and then enrolled into care at the HIV
clinic (78.6% vs 25.0%, p<0.001).
DISCUSSION
The Malawi EID program currently recommends that HIV-infected mothers bring their
infants at 6 weeks of age to an under-five clinic for PCR and evaluation even if the child is
well. In reality, almost half of HIV-exposed infants are not enrolled into EID at these clinics
and never receive a PCR at all or only after acquiring an illness, which is often HIV-
related2,3. Of those infants that receive a PCR at under-five clinics, more than 2/3 fail to
return for their PCR result and do not enroll into EID care2,3. Therefore, alternative EID
entry points require evaluation. The most appealing site for integrating EID programming
would be one that is already routinely used by children and could absorb an additional
service with minimal disruption. For these reasons, we compared a pilot program that
integrated EID into an IC to the current standard of EID at an U5C. Our results clearly
demonstrate that IC EID testing is more feasible for providers, more acceptable for
caregivers of PCR eligible infants, and enrolls and retains greater numbers of younger
patients into EID.
Ideally, EID programs should identify all HIV-exposed infants at the youngest age possible,
prior to HIV-infection, so infants can maximally benefit from early access to HIV PCR
testing, maternal or infant PMTCT interventions, breastfeeding counseling, and
cotrimoxazole prophylaxis. Similarly, early identification of HIV-infected infants is critical
since the greatest survival benefit from ART is realized if it is urgently initiated early in
life2,7. Targeting patients that maximally benefit from these interventions is the best use of
costly EID resources in any situation, but particularly in settings with severe constraints like
Malawi. Opt-out HIV antibody testing of mothers or infants could achieve these goals8.
Importantly, we found that PCR recipients at this IC were younger by 2.5 months with far
less testing PCR positive. Furthermore, HIV-infected infants identified at IC were also
nearly 4 months younger than those at U5C (data not shown). These data strongly support
the notion that PITC at ICs, compared to testing at U5Cs, is a better use of resources by
targeting patients that can benefit the most from EID services.
Given that resources are limited, any further scale-up of EID programming must consider
whether the clinical setting best facilitates the delivery of services to the greatest numbers of
patients. For example, although the two PITC sites utilized similar staffing levels, we found
the proportion of patients offered HIV testing at the IC to be more than seven-times higher
than at the U5C. This striking disparity may be partially explained by the differing
characteristics of the sites with respect to patient acuity and volume. More specifically, most
patients attend the U5C due to an acute illness and often require multiple services including
clinical assessment, laboratories, radiology, and pharmacologic interventions. On the other
hand, most IC attendees are healthy and require only anthropomorphic measurements and
vaccinations. HIV testing at the U5C is made even more difficult by higher patient volumes
(171 vs 52 patients/day at the IC). Overall these findings suggest that ICs may be a more
suitable clinical setting for the most efficient delivery of EID services to the greatest number
of patients.
In addition to targeting the most eligible patient population and selecting the most suitable
clinical setting, client acceptance is another key factor for measuring the success of
integrating EID testing into an existing service. Using PCR acceptance rates and the
retention of PCR recipients as measures of acceptability, this study also indicates that
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caregivers of PCR eligible infants found PITC at an IC more acceptable. No patients
declined PCR testing at the IC, and even more importantly, more than three times more PCR
recipients returned for their PCR result and were enrolled into the EID program. Notably,
these were infants who otherwise may not have accessed PCR without the availability of
integrated IC EID services. Our results strengthen findings from a South African study that
reported similar client acceptance rates of EID testing at ICs9, and taken together may
suggest that the integration of EID services and ICs would be acceptable throughout the
southern African region.
One limitation is this study compares just two urban clinics. While a multisite comparison
including rural clinics is an important next step, we were unaware of other similarly
integrated IC and EID services in Malawi at the time of this study.
In conclusion, we recommend the integration of opt-out HIV testing and counseling at ICs
for all eligible mothers and infants. Scaling up EID testing at ICs is likely to strengthen EID
services in Malawi.
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Study population diagram. HIV indicates human immunodeficiency virus; PCR, polymerase
chain reaction.
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Table 1
Characteristics of Early Infant Diagnosis of HIV Testing at an “Under-Five” General Pediatric Clinic and an
Immunization Clinic
“Under-Five” Clinic (N=877) Immunization Clinic (N=880) P-value
Characteristics of
Study Population
Age in Months, Median (IQR) 17.0 (9.1 – 37.0) 2.6 (1.3 – 7.0) <0.001
Females, n (%) 440 (50.6) 430 (49.1) 0.53
Child's Enrollment HIV status <0.001
    HIV-Uninfected, n (%) 797 (90.9) 724 (82.3)
    HIV-Exposed, n (%) 46 (5.3) 155 (17.6)
    HIV-Infected, n (%) 34 (3.8) 1 (0.1)
PCR test eligible, n (%) 31 (3.5) 70 (7.9) <0.001
Characteristics of HIV
PCR Recipients
PCR test accepted, n/N (%) 28/31 (90.3) 70/70 (100.0) 0.03
Age in Months, Median (IQR) 5.6 (3.3 – 9.1_) 3.1 (2.3 – 5.2) <0.001
Females, n/N (%) 16/28 (57.1) 33/70 (47.1) 0.37
PCR Positive, n/N (%) 9/28 (32.1) 5/70 (7.1) <0.001
Breast feeding, n/N (%) 25/28 (89.3) 69/70 (98.6) 0.06
Child received PMTCT, n/N
1 6/15 (40.0) 60/70 (85.7) <0.001
Mother received PMTCT, n/N (%)
2 7/14 (50.0) 62/69 (89.9) <0.001
Received PCR result, n/N (%) 7/28 (25.0) 55/70 (78.6) <0.001
HIV indicates human immunodeficiency virus; IQR, interquartile range; PCR, polymerase chain reaction; PMTCT, prevention of mother-to-child
transmission.
1
13 children from “Under-Five” Clinic did not have PMTCT information documented.
2
14 mothers from “Under-Five” Clinic and 1 mother from Immunization Clinic did not have PMTCT information documented.
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